0001644472-15-000002.txt : 20150611
0001644472-15-000002.hdr.sgml : 20150611
20150611135529
ACCESSION NUMBER: 0001644472-15-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150611
DATE AS OF CHANGE: 20150611
EFFECTIVENESS DATE: 20150611
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Glycostasis, Inc.
CENTRAL INDEX KEY: 0001644472
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-241544
FILM NUMBER: 15925532
BUSINESS ADDRESS:
STREET 1: 4317 DENSMORE AVE. N.
CITY: SEATTLE
STATE: WA
ZIP: 98103
BUSINESS PHONE: 425-591-9641
MAIL ADDRESS:
STREET 1: 4317 DENSMORE AVE. N.
CITY: SEATTLE
STATE: WA
ZIP: 98103
D
1
primary_doc.xml
X0707
D
LIVE
0001644472
Glycostasis, Inc.
4317 DENSMORE AVE. N.
SEATTLE
WA
WASHINGTON
98103
425-591-9641
DELAWARE
None
None
Corporation
true
2012
John
Mulligan
c/o Glycostasis, Inc.
4317 Densmore Ave. N.
Seattle
WA
WASHINGTON
98103
Executive Officer
Director
Promoter
Biotechnology
Decline to Disclose
- 06b
false
2015-05-28
false
true
false
0
2680050
149998
2530052
false
1
0
0
0
false
Glycostasis, Inc.
/s/ John Mulligan
John Mulligan
Chief Executive Officer
2015-06-11